Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

Stock Information for Exagen Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Exagen Inc.

Exagen to Announce Third Quarter 2024 Results on November 12, 2024
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
Exagen Announces Campaign for Lupus Awareness Month

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.